Substances and compositions for enhancing DNA repair and methods of use
The invention provides methods of preventing or treating a condition associated with DNA damage in an animal comprising the administration of a substance that interferes with the activity of the CUL4A ubiquitin ligase. The invention also provides a substance that interferes with the activity of CUL4A, as well as compositions comprising the interfering substance and a carrier. The substance of the invention preferably enhances nucleotide excision repair activity in an animal. The invention further provides methods of identifying substances that negatively or positively modulate the expression and/or activity of CUL4A.
1. A method of preventing or treating a condition associated with DNA damage in an animal, which method comprises administering to an animal in need thereof an effective amount of a substance that interferes with the activity of CUL4A, thereby preventing or treating a condition associated with DNA damage in the animal.
2. The method of claim 1 , wherein the substance that interferes with the activity of CUL4A causes an increase in DNA repair activity.
3. The method of claim 2 , wherein the increase in DNA repair activity is an increase nucleotide excision repair activity.
4. The method of claim 1 , wherein the condition associated with DNA damage is selected from the group consisting of aging, prolonged exposure to ultraviolet radiation, exposure to a chemical carcinogen, cancer, Xeroderma pigmentosum, Cockayne syndrome, and Ataxia-telangiectasia.
5. The method of claim 4 , wherein the condition associated with DNA damage is cancer, and the cancer is selected from the group consisting of skin cancer, lung cancer, throat cancer, and liver cancer.
6. The method of claim 1 , wherein the substance that interferes with the activity of CUL4A is selected from the group consisting of polypeptides, peptidomimetics and polynucleotides.
7. The method of claim 6 , wherein the substance that interferes with the activity of CUL4A is a polynucleotide, and the polynucleotide is selected from the group consisting of small interfering RNA (siRNA), short hairpin RNA (shRNA), antisense oligonucleotides, aptamers, and ribozymes.
8. The method of claim 1 , wherein the substance that interferes with the activity of CUL4A inhibits the expression of CUL4A.
9. The method of claim 1 , wherein the substance that interferes with the activity of CUL4A disrupts the binding of CUL4A to damaged DNA binding protein 1 (DDB1).
10. The method of claim 9 , wherein the substance that interferes with the activity of CUL4A competitively inhibits the binding of an endogenous CUL4A to DDB1.
11. The method of claim 9 , wherein the substance that interferes with the activity of CUL4A is a polypeptide or peptidomimetic.
12. The method of claim 11 , wherein the polypeptide or peptidomimetic comprises a fragment of CUL4A.
13. The method of claim 1 , wherein the substance that interferes with the activity of CUL4A is administered topically, orally, intranasally, parenterally, enterically, rectally, or ocularly.
14. The method of claim 1 , wherein the substance that interferes with the activity of CUL4A is administered in a composition comprising the inhibitor of CUL4A and a carrier.
15. The method of claim 14 , wherein the composition is a sunscreen composition.
16. The method of claim 15 , wherein the sunscreen composition comprises:
(a) the substance that interferes with the activity of CUL4A,
(b) a photoprotective amount of a sunscreen compound selected from the group consisting of sulisobenzone, dioxybenzone, methyl anthranilate, 4-aminobenzoic acid (PABA), amyl dimethyl PABA, octyl dimethyl PABA, glyceryl PABA, 2-ethoxyethyl p-methoxycinnamate, diethamolamine p-methoxycinnamate, ethylhexyl p-methoxycinnamate, digalloyl trioleate, ethyl 4-bis(hydroxypropyl)aminobenzoate, 2-ethylhexyl-2-cyano-3,3-diphenylacrylate, 2-ethylhexyl salicylate, homomethyl salicylate, triethanolamine salicylate, 2-phenylbenzimidazole-5-sulfonic acid, red petrolatum, titanium dioxide, zinc oxide, and combinations thereof, and
(c) a cosmetically acceptable carrier.
17. The method of claim 1 , further comprising administering a chemotherapeutic agent to the animal.
18. The method of claim 1 , wherein the animal is a human.
19. A composition comprising a substance that interferes with the activity of CUL4A in an animal and a cosmetically acceptable carrier which further comprises a photoprotective amount of a sunscreen compound selected from the group consisting of sulisobenzone, dioxybenzone, methyl anthranilate, 4-aminobenzoic acid(PABA), amyl dimethyl PABA, octyl dimethyl PABA, glyceryl PABA, 2-ethoxyethyl p-methoxycinnamate, diethamolamine p-methoxycinnamate, ethylhexyl p-methoxycinnamate, digalloyl trioleate, ethyl 4-bis(hydroxypropyl)aminobenzoate, 2-ethylhexyl-2-cyano-3,3-diphenylacrylate, 2-ethylhexyl salicylate, homomethyl salicylate, triethanolamine salicylate, 2-phenylbenzimidazole-5-sulfonic acid, red petrolatum, titanium dioxide, zinc oxide, and combinations thereof.
20. The composition of claim 19 , wherein the substance is selected from the group consisting of polypeptides, peptidomimetics and polynucleotides.
21. The composition of claim 19 , wherein the substance is a polynucleotide, and the polynucleotide is selected from the group consisting of small interfering RNA (siRNA), short hairpin RNA (shRNA), antisense oligonucleotides, aptamers, and ribozymes.
22. The composition of claim 19 , wherein the substance that interferes with the activity of CUL4A competitively inhibits the binding of an endogenous CUL4A to damaged DNA binding protein (DDB 1) in an animal.
23. The composition of claim 19 , wherein the substance that interferes with the activity of CUL4A is a polypeptide or peptidomimetic which comprises a fragment of CUL4A.